Cargando…
Nanoparticle-Based Combination Therapy for Ovarian Cancer
Ovarian cancer is one of the most common malignant tumors in gynecology with a high incidence. Combination therapy, eg, administration of paclitaxel followed by a platinum anticancer drug is recommended to treat ovarian cancer due to its advantages in, eg, reducing side effects and reversing (multi)...
Autores principales: | Wu, Yingli, Yang, Yu, Lv, Xiaolin, Gao, Menghan, Gong, Xujin, Yao, Qingqiang, Liu, Yanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106804/ https://www.ncbi.nlm.nih.gov/pubmed/37077941 http://dx.doi.org/10.2147/IJN.S394383 |
Ejemplares similares
-
Platinum-based drugs for cancer therapy and anti-tumor strategies
por: Zhang, Chunyu, et al.
Publicado: (2022) -
Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer
por: Levit, Shani L., et al.
Publicado: (2021) -
Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
por: Zhang, Meng, et al.
Publicado: (2017) -
Nanoparticle-Based Combination Therapy for Melanoma
por: Chen, Hongbo, et al.
Publicado: (2022) -
Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment
por: Yuan, Yu-Guo, et al.
Publicado: (2017)